afstyla powder and solvent for solution for injection 3000iuvial
csl behring pte. ltd. - lonoctocog alfa - injection, powder, lyophilized, for solution - lonoctocog alfa 3000iu/vial
afstyla powder and solvent for solution for injection 500iuvial
csl behring pte. ltd. - lonoctocog alfa - injection, powder, lyophilized, for solution - lonoctocog alfa 500iu/vial
haemocomplettan p powder for solution for injection or infusion 1gvial
csl behring pte. ltd. - human fibrinogen - injection, powder, lyophilized, for solution - human fibrinogen 0.900-1.300 g/vial
idelvion powder and solvent for solution for injection 1000iuvial
csl behring pte. ltd. - albutrepenonacog alfa - injection, powder, lyophilized, for solution - albutrepenonacog alfa 1000iu/vial
idelvion powder and solvent for solution for injection 2000iuvial
csl behring pte. ltd. - albutrepenonacog alfa - injection, powder, lyophilized, for solution - albutrepenonacog alfa 2000iu/vial
idelvion powder and solvent for solution for injection 250iuvial
csl behring pte. ltd. - albutrepenonacog alfa - injection, powder, lyophilized, for solution - albutrepenonacog alfa 250iu/vial
idelvion powder and solvent for solution for injection 500iuvial
csl behring pte. ltd. - albutrepenonacog alfa - injection, powder, lyophilized, for solution - albutrepenonacog alfa 500iu/vial
berirab
csl behring ltd., israel - human-rabies immunoglobulin - solution for injection - human-rabies immunoglobulin 150 iu/ml - rabies immunoglobulin - rabies immunoglobulin - prophylaxis of rabies.
berinert iv human c1 esterase inhibitor 1500 iu powder for injection vial with diluent vial
csl behring australia pty ltd - water for injections, quantity: 3 ml - injection, diluent for - excipient ingredients: - berinert iv is indicated for the treatment of acute attacks in patients with hereditary angioedema (hae).
beriplex p/n human prothrombin complex 1000 iu powder for injection vial
csl behring australia pty ltd - water for injections, quantity: 40 ml - injection, solution - excipient ingredients: - treatment and perioperative prophylaxis of bleedings in acquired deficiency of the prothrombin complex coagulation factors, such as deficiency caused by treatment with vitamin k antagonists, or in case of overdose of vitamin k antagonists, when rapid correction of the deficiency is required.